Raphael Pharmaceutical Inc. (RAPH) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$1.25M | +17.5% |
| 2024 | -$1.51M | -13.3% |
| 2023 | -$1.33M | +59.8% |
| 2022 | -$3.32M | -103.6% |
| 2021 | -$1.63M | -130.7% |
| 2020 | -$706.0K | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$1.25M | +17.5% |
| 2024 | -$1.51M | -13.3% |
| 2023 | -$1.33M | +59.8% |
| 2022 | -$3.32M | -103.6% |
| 2021 | -$1.63M | -130.7% |
| 2020 | -$706.0K | — |